Information for Genzyme Investors

We have detected that your browser does not have Javascript turned on. This site is optimized for Javascript.
You may experience difficulties browsing certain parts of the site.

Home

Global Locations

Genzyme Websites

Corporate Info

Investors

	Financial News
	Investor Events
	Financial Reports
	Guidance and Reconciliation
	Research Pipeline
	Analyst Coverage
	Corporate Governance
	Frequently Asked Questions

Investors

Genzyme Stock (GENZ) is listed on the NASDAQ.

Earnings Reporting Dates

Q1 10

April 21, 2010

Q2 10

July 21, 2010

Q3 10

October 20, 2010

Q4 10

February 16, 2011

Corporate Governance
View our guidelines, board composition and charters.
More >

News Subscription
Subscribe to our email news service. More >

Investor Events
View a list of our upcoming conferences and webcasts. More >

	Highlight

	Genzyme Upcoming Events Visit the Investor Events section of our website for information on future conferences and events. Bank of America Merrill Lynch Global Healthcare Conference September 15-17, 2010 London, UK


	CONTACT INFORMATION:
	Genzyme Investor Relations 500 Kendall Street Cambridge, MA 02142 T: 617 252 7500 Patrick Flanigan – 617 768 6563 Investor Information Line U.S. T: 800 905 4369 Outside the U.S. T: 678 999 4572 Shareholder Contact For questions about your shares, replacement of a lost stock certificate or a change of address call our transfer agent. American Stock Transfer 59 Maiden Lane New York, NY 10038 T: 212 936 5100 or Genzyme Shareholder Services T: 617 768 6686